SCHEMBL6137840

SCHEMBL6137840

Cc1ccc(C(=O)N(CCOc2ccccc2)C(=N)N)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN5A Q14524 2/20 0.49
SCN2A Q99250 2/20 0.49
PARP10 Q53GL7 2/20 0.48
KCNA5 P22460 1/20 0.44
RAB9A P51151 3/20 0.44
NPC1 O15118 2/20 0.44
USP2 O75604 1/20 0.44
TP53 P04637 1/20 0.44
KMT2A Q03164 1/20 0.44
PKM P14618 1/20 0.43
MAPT P10636 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
F10 P00742 1/20 0.41
F2 P00734 1/20 0.41
PLG P00747 1/20 0.41
PRSS1 P07477 1/20 0.41
PRSS2 P07478 1/20 0.41
C1S P09871 1/20 0.41
PRSS3 P35030 1/20 0.41
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6137598 0.89 DRD2 (0.53) PARP10KCNA5RAB9ANPC1KMT2A
SCHEMBL6137702 0.77 MEN1 (0.47) SCN2ARAB9ANPC1KMT2AMAPT
SCHEMBL11555105 0.75 TDP1 (0.40) PARP10RAB9ANPC1KMT2AL3MBTL1
SCHEMBL6138068 0.74 NPC1 (0.39) RAB9ANPC1KMT2AMAPTLMNA
SCHEMBL11557507 0.72 LTA4H (0.39) PARP10RAB9AKMT2AL3MBTL1F2
SCHEMBL6137717 0.72 ALOX12 (0.47) SCN5ASCN2APARP10RAB9ANPC1
SCHEMBL11877246 0.71 BCHE (0.53) RAB9ANPC1TP53KMT2AMAPT
SCHEMBL14366326 0.70 GAA (0.63) SCN5ASCN2APARP10KCNA5RAB9A
SCHEMBL5968220 0.70 RAB9A (0.64) RAB9ANPC1KMT2APKMMAPT
SCHEMBL8582839 0.70 HPGD (0.44) RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1032556-A4 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE INC (US) 2005-02-02 EP claimed
EP-1032556-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE, INC. (US) 2000-09-06 EP claimed
WO-1999020599-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE, INC. (US) 1999-04-29 WO claimed